It is a healthcare private limited company based in Secunderabad, Telangana, India, established in 2012.
2012 | Secunderabad, Telangana, India | Struck OffSls Cell Cure Technologies Private Limited, a struck off private limited company, was established on 28 September 2012 in Secunderabad, Telangana, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U73100TG2012PTC083318. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shivraj Livy (Director), Smita Shivraj Dasari (Director). Past directors included Shivraj Dasari, Smita Shivraj Dasari. Its latest AGM occurred on 28 September 2019, with the balance sheet filed on 31 March 2019. It is based at Flat No. 103, Prabhat Apartments Street No 11, East Maredpally,, Secunderabad, Telangana, 500026.
U73100TG2012PTC083318
083318
28 September 2012
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Sls Cell Cure Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivraj Livy | Director | 28 Sep 2012 | Current |
| Smita Shivraj Dasari | Director | 26 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sls Cell Cure Technologies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Sls Cell Cure Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sls Cell Cure Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sls Cell Cure Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sls Cell Cure Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sls Cell Cure Technologies Private Limited last Annual general meeting of members was held on 28 Sep 2019 as per latest MCA records. was completed.
The activity Sls Cell Cure Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was completed.
The activity Smita Shivraj Dasari was appointed as a Director was appointed as a Director on 26 Dec 2018 & has been associated with this company since 7 years 1 day . was completed.
The activity Shivraj Livy was appointed as a Director was appointed as a Director on 28 Sep 2012 & has been associated with this company since 13 years 2 months . was completed.
Sls Cell Cure Technologies Private Limited was registered on 28 Sep 2012 with Roc Hyderabad & aged 13 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Sls Cell Cure Technologies Private Limited is U73100TG2012PTC083318.
Sls Cell Cure Technologies Private Limited is headquartered at Flat No. 103, Prabhat Apartments Street No 11, East Maredpally,, Secunderabad, Telangana, 500026.
Sls Cell Cure Technologies Private Limited was incorporated on 28 September 2012.
The current directors of Sls Cell Cure Technologies Private Limited are
The primary industry of Sls Cell Cure Technologies Private Limited is Hospital And Medical Care.
Sls Cell Cure Technologies Private Limited is unlisted.
The authorized capital of Sls Cell Cure Technologies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sls Cell Cure Technologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX